Uchiumi T, Longo D L, Ferris D K
Laboratory of Leukocyte Biology, Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA.
J Biol Chem. 1997 Apr 4;272(14):9166-74. doi: 10.1074/jbc.272.14.9166.
Plk (polo-like kinase) is a serine-threonine kinase that appears to function in mitotic control in mammalian cells. We demonstrated previously that PLK mRNA expression is low at the G1-S transition, increases during S phase, and is maximally expressed during G2-M. In the present study, we have cloned the human PLK gene and analyzed the structure and function of 2 kilobases of its 5'-flanking region. Using synchronized cultures of HeLa cells transfected with PLK promoter/luciferase constructs, we show that the promoter of PLK is activated at S phase and is maximal at G2-M phase. Using various PLK promoter/luciferase constructs, we show that three activating regions are located between 35 and 93 base pairs upstream of the transcription initiation site. We identified a repressor element (CDE/CHR) in the region of the transcription start site, and mutations within this element diminished cell cycle regulation of transcription.
Polo样激酶(Plk)是一种丝氨酸-苏氨酸激酶,似乎在哺乳动物细胞的有丝分裂控制中发挥作用。我们先前证明,PLK mRNA表达在G1-S期转换时较低,在S期增加,并在G2-M期达到最大表达。在本研究中,我们克隆了人PLK基因,并分析了其5'侧翼区2千碱基的结构和功能。使用转染了PLK启动子/荧光素酶构建体的HeLa细胞同步培养物,我们表明PLK启动子在S期被激活,并在G2-M期达到最大活性。使用各种PLK启动子/荧光素酶构建体,我们表明三个激活区域位于转录起始位点上游35至93个碱基对之间。我们在转录起始位点区域鉴定出一个阻遏元件(CDE/CHR),该元件内的突变减少了转录的细胞周期调控。